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Medical certification to return to work after coronary
bypass surgery in occupations that carry a risk to public
safety is controversial, particularly for airline pilots. To
address this issue, 10,312 patients from the CASS re-
gistry who underwent coronary bypass surgery were
studied and 2,326 men with clinical and postoperative
characteristics similar to those of the average airline pilot
who might apply to renew his license after surgery were
selected.
The 5 year probability of remaining free of an acute
cardiac event, defined as acute coronary insufficiency,
myocardial infarction or sudden death, was 0.92 ± 0.01
(mean ± SE) for the 1,207 men without previous myo-
cardial infarction and 0.98 ± 0.01 for the 122 men who
never smoked and did not have a history of hypertension.
Among the 1,119 men with a previous myocardial in-
farction, the probability of remaining free of acute car-
The question of whether an airline pilot should be recertified
to active flight status after coronary bypass surgery remains
controversial (1-5). The number of commercial and private
pilots has dramatically increased in the last decade as a result
of major growth in the airline industry. The number of
coronary bypass operations has also increased. In the last
few years, unlimited first-class medical certificates have
*A list of the participating clinical sites and investigators appears in
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diac events was 0.91 ± 0.02 and 0.92 ± 0.02 when left
ventricular contraction score was 5 to 9 and 10or greater,
respectively. In this patient subgroup, mortality rate was
similar to that of the age-matched U.S. male population
when the left ventricular contraction score was 5 to 9
(4.0% versus 4.3%; p = NS) but significantly worse
when the left ventricular contraction score was 10 or
greater (7% versus 4.2%; p = 0.05).
The data from this CASS registry study are pertinent
to the question of operationally unlimited first-class med-
ical certification of carefully selected airline pilots after
coronary bypass surgery. The data are also relevant to
the issue of medical certification after coronary bypass
surgery for individuals in other occupations in the trans-
portation industry where public safety is an issue.
(J Am Coll CardioI1986;8:1318-24)
been granted to approximately 50 commercial airline pilots
after coronary bypass surgery. Criteria used to make this
decision included the absence of cardiac symptoms, absence
of objective evidence of significant stress-induced myo-
cardial ischemia and, in most cases, documentation of ad-
equate coronary revascularization at follow-up angiography
(Frank H. Austin, MD, U.S. Federal Air Surgeon, personal
communication). Recertification of these pilots has resulted
in some controversy in the aeromedical and specialty com-
munities.
The argument for recertification is based on identifying
a patient subgroup with a very low risk of cardiac events
and on the fact that multicrew aircraft are used for passenger
air transportation, and for compromised function to occur,
a sudden unnoticed incapacity must affect the pilot at the
controls during a critical time of takeoff or final approach
and landing.
Airline pilots who are given functionally unlimited first-
class medical certificates after coronary bypass surgery are
0735-1097/86/$3.50
Table 1. Exclusion Criteria Used to Select "Simulated Aviator
Population" From 10,312Consecutive Patients Who Underwent
Coronary Bypass Surgery in CASS
CABO = coronary artery bypass grafting ; CHF = congestive heart
failure; CS = cardiac symptoms; DBP = diastolic blood pressure; MI =
myocardial infarction ; SBP = systolic blood pressure. The exclusion cri-
teria are not mutually exclusive.
also excluded. Selection characteristics used to define
this "simulated aviator population" are summarized in
Table I.
Follow-up. The follow-up period started 12 months from
the date of coronary bypass surgery ; patients were examined
at 12 month intervals for the duration of follow-up. Details
concerning events such as death , hospitalization for new or
recurrent cardiovascular symptoms such as angina, acute
coronary insufficiency, dyspnea, myocardial infarction,
congestive heart failure, stroke or rhythm disturbances were
routinely recorded. Acute coronary insufficiency was de-
fined as episodes of chest pain lasting longer than 30 min-
utes, unresponsive to standard therapy and associated with
transient ST or T wave changes . Myocardial infarction was
diagnosed from the presence of chest pain, electrocardio-
graphic abnormalities and changes in myocardial serum en-
zymes . Sudden death was defined as death occuring within
I hour of the onset of symptoms and generally before the
availability of medical attention. Vital status was known for
99.8% of the participating patients as of December 1982.
Four patients were lost to follow-up after 2, 2Y2, 4 and 6
years , respectively. The average duration of follow-up was
52 :t 16 months; 87% of the patients had been followed
up for 48 months, 66% for 60 months , 39% for 72 months
and 13% for 84 months . The selected clinical characteristics
of the study group are summarized in Table 2. Left ven-
tricular cineangiography was carried out in the 30° right
anterior oblique view; the ventriculogram was divided into
five segments (8). The systolic motion of each segment was
recorded and scored numerically as follows: normal = I,
moderate hypokinesia = 2, severe hypokinesia = 3, aki-
nesia = 4, dyskinesia = 5, aneurysmal dilation = 6.
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carefully followed up with a physical examination every 6
months, a complete clinical cardiovascular consultation, ap-
propriate laboratory studies and a maximal symptom-limited
exercise test each year. The waiting period from the time
of operation to application for a license is between 6 months
and 1 year; the noninvasive evaluation performed after coro-
nary bypass surgery may include a maximal exercise thal-
lium study or a rest and exercise gated blood pool study,
careful review of the surgical report and a review of the
preoperative coronary angiogram. Approved cardioactive
medication in standard doses , unassociated with side effects ,
is permitted (Frank H, Austin, MD, personal communica-
tion, 1986).
Commercial aviators represent a select group that may
have a lower risk of cardiovascular events than the general
population. The presence of uncontrolled hypertension, in-
sulin-dependent diabetes , important electrocardiographic
abnormalities and an age of 60 years or greater results in
loss of license for air carrier flying (I) . The incidence of
sudden cardiac incapacitation after coronary bypass surgery
in such patients is unknown. Clearly, gathering this type of
data would be in the public's interest.
The aim of the present study was to select a group of
patients from the CASS registry who had baseline charac-
teristics similar to those of the average airline pilot and who
underwent coronary bypass surgery . The risk of acute car-
diac events was determined in this study group over an
average follow-up period of 5.6 years and the mortality risk
was compared with an age- and sex-matched U.S. popu-
lation sample (6).
Methods
Selection of patients. The Coronary Artery Surgery Study
(CASS) registry contains 24,959 patients who underwent
coronary angiography between 1974 and 1979 for suspected
or proved coronary artery disease (7) (see Appendix). Dur-
ing this time, 10,312 patients underwent coronary artery
bypass surgery . The study population contains 2,326 men
who were less than 60 years at the time of surgery and had
no previous history of coronary bypass surgery, congestive
heart failure, stroke, cancer or diabetes requiring insulin or
oral hypoglycemic drugs. Patients who had cardiac enlarge-
ment on chest roentgenogram or moderately elevated blood
pressure on screening examination before angiography (sys-
tolic blood pressure >200 mm Hg or diastolic blood pres-
sure > 100 mm Hg) or those patients who sustained a
perioperative myocardial infarction during the coronary by-
pass procedure were excluded to simulate data available to
the Federal Aviation Administration at the time that medical
certification is requested after coronary bypass surgery. Any
patient who developed a myocardial infarction or was hos-
pitalized for chest pain, congestive heart failure, a rhythm
disturbance or stroke within 12 months after surgery was
Age > 60 years
Female
Prior CABO
History of CHF
History of stroke
History of cancer
Diabetes
Cardiomegaly on chest X-ray film
SBP ~200 or DBP ~IOO mm Hg
Perioperative MI
Death within 12 mo of CABO
MI within 12 mo of CABO
Other CS within 12 mo of CABO
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274
995
293
518
543
1,373
370
537
490
387
3,287
1319
%
26
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3
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3
5
5
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4
5
5
4
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Table 2. Selected Clinical Characteristics of the Study Population and Cardiac Event Rates
Previous MI
No Previous MI LV Score 5 to 9 LV Score >10 Total Pop
No. of subjects 1,207 665 454 2,326
Av age (yr) 49.5 ± 6 49.2 ± 6 48.8 ± 7 49.3 ± 6
CAO
One 321 (27%) 121 (18%) 40(9%) 482 (21%)
Two 406 (34%) 243 (37%) 144 (32%) 793 (34%)
Three 472 (39%) 297 (45%) 265 (59%) 1,034 (45%)
LMCO 2:70% 122 (10%) 30 (5%) 29 (6%) 181 (8%)
Av LVEOP (mm Hg) 11.9 ± 6 12.3 ± 6 15.4 ± 7 12.7 ± 6
Av LV score 5.8 ± I 6.6 ± I 12.7 ± 2 7.4 ± 3
% Patients with EF <0.50 70 (7%) 88 (17%) 194 (64%) 352 (20%)
Grafts (no.)
One 226 (20%) 79 (12%) 45 (10%) 350 (16%)
Two 397 (35%) 248 (39%) 157 (36%) 802 (36%)
Three 499 (44%) 303 (47%) 230 (52%) 1,032 (47%)
Av duration follow-up (mo) 52.2 ± 16 52.4 ± 15 49.5 ± 16 51.7 ± 16
Sudden death (SO) 10 (1%) 7 (1%) 8 (2%) 25 (1%)
Myocardial infarction (MI) 55 (5%) 29 (4%) 15 (3%) 99 (4%)
Acute coronary insufficiency (ACI) 6 (1%) 5 (1%) 3 (I %) 14(1%)
SO or MI or ACI 67 (6%) 41 (6%) 26 (6%) 134 (6%)
Nonsudden cardiac death 4 (0.3%) 3 (0.5%) 8 (2%) 15 (I %)
Noncardiac death 10(1%) 12 (2%) 5 (1%) 27 (1%)
Av = average; CAO = coronary artery disease with number of vessels with luminal narrowing 2:70%; EF = ejection fraction (mean ± SO);
LMCO = left main coronary disease; Lv = left ventricular; LVEOP = left ventricular end-diastolic pressure; Pop = population.
Patient subgroups. The 2,326 patients in the simulated
aviator group were divided into subgroups based on the
presence or absence of previous myocardial infarction. Among
the 1,207 men without previous infarction, 671 had a normal
left ventricular contraction pattern and 536 had a left ven-
tricular contraction score of 6 to 9 (mild abnormality). The
incidence of subsequent cardiac events was similar in both
subgroups, and the data are combined for the purpose of
this report.
The second group of patients consisted of 1,119 men
who had a previous myocardial infarction; 665 had a left
ventricular contraction score of 5 to 9, and 454 had a score
of 10 or greater (moderate to severe abnormality).
Coronary bypass surgery was performed using the stan-
dard techniques of anesthesia, myocardial preservation and
graft anastomoses at each of the 15 participating hospitals.
Patients who had associated cardiac procedures such as valve
replacement, ventricular aneurysm resection or ventricular
plication were excluded. The average duration of cardio-
pulmonary bypass time was 102.5 ± 47 minutes and the
mean number of grafts inserted was 2.4 ± 1.
Data analysis. Group differences at baseline were as-
sessed by the chi-square test for discrete variables; the two
sample t test was used for continuous variables. An acute
cardiac event was defined as the first occurrence of acute
coronary insufficiency, myocardial infarction or sudden death.
The incidence of acute cardiac events over 5 years was
estimated by life table analyses. Patients were included in
end point analyses until the occurrence of a) 60 years of
age, b) hospitalization for cardiac causes, c) last CASS
follow-up, or d) death. Event rate curves for all patients are
shown to 5 years. The small number of patients followed
up beyond 5 years makes estimates beyond this point un-
stable. Cumulative event rates for patients were compared
by log rank statistic computed on the entire follow-up ex-
perience (9). The observation period was calculated as be-
ginning 12 months from the day of operation.
The survival rates observed in this simulated aviator
population were compared with the survival rate for U.S.
men obtained over the same time period from the U.S. life
tables (6) and were adjusted for age to match the three study
populations: men with no previous history of myocardial
infarction, men with a previous myocardial infarction and
a mild left ventricular contraction abnormality and men with
a previous myocardial infarction and moderate or severe
contraction abnormalities.
Cox regression analyses. The relative importance of
clinical and angiographic variables in determining end points
was assessed with a stepwise Cox survival analysis (10).
The variables used in this analysis were: age, number of
grafts inserted, revascularization index, number of diseased
vessels with 70% or greater luminal narrowing, smoking
history, history of hypertension, family history of cardio-
vascular disease before age 55, recreational level, antiar-
rhythmic drug therapy, ST segment depression of 1.0 mm
or greater on baseline electrocardiogram, presence of car-
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diac arrhythmias on baseline electrocardiogram, serum cho-
lesterol, ejection fract ion, ST segment depression on the
postoperat ive electrocardiogram and cardiac arrhythmias on
the postoperative electrocardiogram. Separate Cox analyses
were performed adding each of the last four variables, be-
cause these data were only present for a subset of patients .
The smoking history was classified as a trichotomous vari-
able (never smoked , former smoker or smoker at the time
of operation) . The hypertension variable was classified as
either no previous history or a previous history of hyper-
tension .
Results
Cardiac events . The 5 year probability of remaining
free of acute cardiac events stratified by age was similar in
each of the three patient subsets and ranged from 90 to 94%
(Table 3). When the total group was considered, the 5 year
probability of remaining free of an acute cardiac event in
men aged 40 to 49 years was 0.91 ::!: 0 .02,0.85 ::!: 0.03
and 0.96 ::!: 0.01 for the 194, 285 and 349 patients with
one , two and three vessel coronary disease, respectively
(p = 0.004). Among the men aged 50 to 59 years, the 5 year
incidence was 0 .93 ::!: 0 .03 ,0.92 ::!: 0 .02 and 0.92 ::!: 0.02
for the 228 , 439 and 6 19 patients with one, two and three
vessel disease , respectively (p = NS).
Survival rates. The survival rates in this simulated avia-
tor populaton were compared with survival rates for U.S.
white men. Survival rates for the patients without previous
myocardial infarction were significantly greater than the rates
for age-matched U.S. men (p = 0.03; Fig . IA). For the
subgro up of patients with previou s myocardial infarction
and a left ventricular contraction score of 5 to 9, the event
rates were not significantly different than those of age-matched
U.S. men (p = 0.98; Fig. IB) . For the subgroup of patients
with previous myocardial infarction and a left ventricular
contraction score of 10 or greater, the survival rates were
significantly less than the rates for U.S . men (p = 0.05;
Fig. IC), although the difference was small.
Cox regression analyses. A Cox regression analysis of
14 clinical and angiographic variables , selected smoking
history and mild hypertension are the only statistically sig-
nificant independent predictors of subsequent acute card iac
events among patients without a previous history of myo-
cardial infarction (p < 0.0 I) . Angiographic variab les such
as ejection fraction and number of preoperative diseased
vessels were not selected , possibly because of the entry
criteria.
The 5 year probability of remaining free of an acute
cardiac event in patients without previous myocardial
infarction or a history of hypertension was 0 .98 ::!: 0 .01,
0.95 ::!: 0 .02 and 0.89 ::!: 0.02 for patients who never
smoked, were former smokers or who smoked at the time
of enrollment, respectively (Fig . 2). Among hypertensive
patients, the probability for those who never smoked, were
former smokers and were current smokers was 0 .93 ::!: 0.03 ,
0.91 ::!: 0 .04 and 0 .86 ::!: 0 .04, respectively (Fig. 3). Smok-
ing and hypertension were not selected by the Cox regression
analyses in patients with a previous history of myocardial
infarction .
Discussion
Data from this study of highly selected patients reveal a
relatively low probability of developing an acute cardiac
event in the 5 to 7 years after successful coronary bypass
surgery with follow-up data starting I year postoperatively .
In the subgroup of patients without a previous myocardial
infarction, the survival rate of the simulated pilot population
was greater than the rate estimated in an age-matched U.S .
male populat ion (6). For the subgroup of patients with a
previous myocardial infarction and relatively well preserved
left ventricular function, the survival rate was similar to that
of U.S . men of the same age; there was a small but sig-
Table 3. Five Year Probability of Remaining Free of Acute Cardiac Events in a " Simulated Aviator Population" Stratified by Age
Age 20 to 39 yr
No .
Probabilit y ± SE
Age 40 to 49 yr
No .
Probability ± SE
Age 50 to 59 yr
No.
Probabil ity ± SE
Total
No.
Probabil ity ± SE
No Previous MI
9 1
0.94 ± 0.0 3
438
0 .91 ± 0.02
678
0.93 ± 0.02
1.207
0 .92 ± 0.01
Previou s MI
Total
LV Score 5 to 9 LV Score > 10 Population
55 51 197
0 .91 ± 0 .05 0.94 ± 0 .03 0 .93 ± 0 .02
240 158 836
0.91 ± 0 .02 0 .90 ± 0 .03 0.9 1 ± 0 .0 1
370 245 1,293
0 .90 ± 0 .03 0 .93 ± 0.02 0.92 ± 0.01
665 454 2,326
0 .9 1 ± 0.02 0.92 ± 0 .02 0.92 ± 0.01
Abbreviations as in Tables 1 and 2.
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Figure 2. Among the 838 patients without previous myocardial
infarction and without a history of hypertension, the 5 year prob-
ability of remaining free of acute cardiac events was excellent in
patients who never smoked or were former smokers. The event
rate was greater in patients who smoked at the time of enrollment
into the CASS registry. % on the abscissa = percent of patients
free of an acute cardiac event. Stat = statistic.
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Figure 3. Among the 345 patients without a previous myocardial
infarction or a history of hypertension at baseline (see text for
definition), the acute cardiac event rate was lowest in patients who
never smoked and highest in patients who smoked at the time of
enrollment.
Comparative cardiac event rates. A follow-up cardiac
event in this study was defined as acute coronary insuffi-
ciency, myocardial infarction or sudden death. This defi-
nition has not been used in reports of asymptomatic subjects
studied over time. In a study by Elveback et al. (II), the
initial occurrence of angina, myocardial infarction or sudden
death was reported for residents of Rochester, Minnesota.
The incidence was 0.3%/year for the age group 30 to 59
years. The annual incidence of myocardial infarction in
asymptomatic men was 0.19,0.43 and 0.93% for men aged
35 to 44, 45 to 54 and 55 to 64 years, respectively, in the
Framingham study (12). The data from these reports and
others (11-13) of men under 60 years free of clinical coro-
nary artery disease give a range of 0.2 to O.4%/year for
angina pectoris, 0.2 to 0.7%/year for myocardial infarction
4 5
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3
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nificant decrease in the survival rate of patients with previous
myocardial infarction who had moderate to severe left ven-
tricular dysfunction. The age-matched U.S. male population
provides a reference group whose data can be compared
with our data. However, commercial aviators are a select
group and may have a better prognosis than that of the
general public (1).
Figure 1. Survival rates. A, Survival rate of 1,207 men without
previousmyocardialinfarction aftercoronarybypasssurgery(CASS)
compared with that of the age-matched V.S. male population. At
5 years, survival was significantly greater in the CASS patients.
Both curves are censored at age 60 years. The survival curves are
compared using the log rank statistic. B, The survival rate of CASS
patients with a previous myocardial infarction and left ventricular
contraction score of 5 to 9 was similar to that of the age-matched
V.S. male population (p = NS). C, When patients with previous
myocardial infarction and a left ventricular contraction score of
10 or greater were compared with the age-adjusted V.S. male
population, survival was significantly worse in the CASS patients
(p = 0.05).
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and 0, I to O.4%/year for sudden death. The risk of any of
these events occurring ranges from 0.3 to I,O%/year, in-
creasing with age, The average annual risk of sudden in-
capacitation in our patients without previous myocardial
infarction was I,6%/year. The probability of sudden inca-
pacitation during flying is clearly less. The estimated risk
of an event occurring during 1,000 hours of flying is 0,2%
(1.6 X 1000)/8,760, and the risk during an estimated 30
critical hours of takeoff and landing is 0.006% (1.6 x 30)/
8,760. The critical period of time spent for takeoff and
landing varies among airlines and is related to pilot assign-
ments and distance between connecting cities, Although the
calculations are based on the fact that the risk is distributed
equally among flying and nonflying times during the year,
any increment in risk is clearly small over this relatively
short time span. When the subgroup of nonsmoking, non-
hypertensive patients was analyzed, the annual acute cardiac
event rate was even lower (0.4%), These numbers compare
favorably with those of the asymptomatic age-matched pop-
ulation,
Cardiac event rates after bypass surgery in airmen.
Hammond et al. (14) reported follow-up data on 234 airmen
with an average age of 50 years whose applications were
approved for active flight status after coronary bypass sur-
gery performed between 1970 and 1980. Criteria for ap-
plication disapproval were evidence of angina, presence of
left main coronary artery disease, poor left ventricular func-
tion, occluded grafts or incomplete revascularization. The
probability of remaining free of cardiac events, defined as
an adverse change in the electrocardiogram, an abnormal
exercise tolerance test, onset of angina pectoris, myocardial
infarction or the need for a second coronary bypass oper-
ation, was 83% in the 5 years after surgery. This event rate
was significantly higher than in the CASS report, which
used acute coronary insufficiency, myocardial infarction and
sudden death to define cardiac causes of sudden incapaci-
tation. Syncope was not coded on CASS follow-up forms
and is not included among the causes of sudden cardiac
incapacitation. The 5 year survival rate was 91%, slightly
lower than that in the CASS study for men with a normal
or mildly abnormal left ventricular contraction pattern. The
survival rate of nonsmokers was significantly higher than
that of smokers in both reports. In the CASS study, baseline
and follow-up data were obtained prospectively and vital
status was known for 99.8% of the participating patients;
in the report by Hammond et al. (14), 66 patients were lost
to follow-up or had incomplete data. The patients in the
CASS study were highly selected to reflect the type of airline
pilot who might apply for recertification after coronary by-
pass surgery and whose medical findings will be reviewed
by Federal Aviation Authorities.
Clinical considerations. Maximal exercise testing (with
or without a radionuclide procedure) is useful in detecting
residual myocardial ischemia, assessing graft patency and
obtaining an estimate of the risk of subsequent cardiac events
after coronary bypass surgery (15-17). This procedure is
required as part of the data used to determine active flight
status approximately I year after coronary bypass surgery.
We did not routinely collect exercise test data in our patients.
The degree of revascularization as assessed by postoperative
coronary angiography is also useful in determining the risk
of subsequent cardiac events (18-20). However, it would
appear from our data that routine postoperative coronary
angiography to assess risk in an airline pilot may not be
necessary in the specific subgroup of nonsmoking, nonhy-
pertensive patients who have a normal maximal exercise
test.
Guidelines for medical certification. Coronary artery
disease is a progressive illness and revascularization pro-
cedures such as coronary artery bypass surgery are palliative
forms of treatment (21-26). Progression of disease in non-
grafted coronary arteries is unpredictable in the individual
patient, although analysis of group data reveals such pro-
gression in approximately 4 to 5% of vessels per year during
the initial II postoperative years (21). In the CASS ran-
domized trial (22), cumulative vein graft patency was 90%
at 60 days and 82% at 5 years, Data from the Montreal
Heart Institute (23) show that the attrition rate of saphenous
vein grafts from atherosclerosis increases between 6 and II
years after surgery. Several studies (25,26) have shown
significantly greater long-term patency using the internal
mammary artery conduit as opposed to a saphenous vein
graft. These data require careful consideration in determin-
ing guidelines regarding medical certification and the length
of time that an airline pilot should be permitted to fly after
coronary bypass surgery. The data from this report suggest
that the risk of an acute cardiac event or death is low in
patients with normal or relatively well preserved left ven-
tricular function in the initial 7 years, and for this highly
selected subgroup of CASS patients, the risk appears to
compare favorably with the U.S. male population of similar
age.
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Joan Coggin. MD.
Marshfield Medical Foundation, Inc. and Marshfield Clinic,
Marshfield WI. William Myers, MD, Richard D. Sautter, MD, John N.
Browell, MD, Dieter M. Voss, MD, Robert D. Carlson, MD.
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MD. W. Gerald Austen, MD, Robert Dinsmore, MD, Frederick Levine,
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Mayo Clinic and Mayo Foundation, Rochester, MN. Robert L. Frye,
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MD, Airlie Cameron, MD.
Stanford University, Stanford, CA, Edwin Alderman, MD, Francis
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